Publications by authors named "C Vavouli"

• Page 1 of 4

Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study.

Irene Stefanaki Ioannis-Alexios Koumprentziotis Natalia Rompoti Pantelis Panagakis Charitomeni Vavouli

Int J Dermatol

January 2025

View Article and Find Full Text PDF

Single-center experience with bimekizumab in psoriasis patients with previous exposure to interleukin-17 inhibitors.

Ioannis-Alexios Koumprentziotis Natalia Rompoti Irene Stefanaki Charitomeni Vavouli Maria Politou

Int J Dermatol

December 2024

View Article and Find Full Text PDF

Switching within the class of IL-17 inhibitors for the treatment of plaque psoriasis: A real-world retrospective study.

Ioannis-Alexios Koumprentziotis Natalia Rompoti Irene Stefanaki Charitomeni Vavouli Marina Papoutsaki

Australas J Dermatol

December 2024

View Article and Find Full Text PDF

Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study.

Natalia Rompoti Ioannis-Alexios Koumprentziotis Irene Stefanaki Charitomeni Vavouli Marina Papoutsaki

Arch Dermatol Res

October 2024

View Article and Find Full Text PDF

Real-world effectiveness and drug survival of guselkumab over a period of 3 years in moderate-to-severe plaque psoriasis, including difficult-to-treat areas.

Natalia Rompoti Theognosia Vergou Irene Stefanaki Charitomeni Vavouli Ioannis-Alexios Koumprentziotis

Int J Dermatol

October 2024

View Article and Find Full Text PDF

• 1 (current)
• 2
• 3
• 4

Privacy Policy Site Map

Contact Us

© LitMetric 2025. All rights reserved.